Latest stories on SNY
Sanofi Shares Hit 5-week High
Trading Economics63 · neutralgeneral
Can French drugmaker Sanofi fix its pipeline?
Financial Times42 · neutralgeneral
Regeneron’s Billion-Dollar Catalyst Flying Under Wall Street’s Radar Ahead of Oct. 30 Earnings
24/7 Wall St.64 · neutralearnings
Sanofi: An Alluring And Balanced Mix Of Yield And Growth
Seeking Alpha63 · neutralanalyst
Novartis Says MS Pill Helped Control Disease With Favorable Safety Data in Trials
Morningstar64 · neutralproduct/pr
Sanofi: Why The Market Seems To Be Overpricing Pipeline Risk
Seeking Alpha63 · neutralanalyst
Sanofi (SNY) Teams With ScionxBio to Pursue Long-Acting mRNA Candidates Using the TERA Platform
October 20, 2026
MarketChameleon63 · neutralproduct/pr
Sanofi, ScionxBio enter collaboration, licensing agreement
The Fly61 · neutralproduct/pr
UEG Week: Teva and Sanofi’s Duvakitug Maintained Long-Term Positive Outcomes in New Phase 2b Data for Ulcerative Colitis and Crohn’s Disease
Business Insider64 · neutralproduct/pr
UEG Week: Teva and Sanofi’s Duvakitug Maintained Long-Term Positive Outcomes in New Phase 2b Data for Ulcerative Colitis and Crohn’s Disease
GlobeNewswire64 · neutralproduct/pr
Sanofi’s China Vaccine Trial Nears Data Reveal: What Investors Should Watch
TipRanks56 · neutralproduct/pr
ISPE Names Sanofi S.A. the 2026 ISPE Facility of the Year Awards (FOYA) Overall Winner for its Modulus Project
PR Newswire61 · neutralproduct/pr
Sanofi breaks ground on new insulin manufacturing facility in Germany
Seeking Alpha61 · neutralproduct/pr
Press Release: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany
Business Insider58 · neutralproduct/pr
Press Release: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany
GlobeNewswire58 · neutralproduct/pr
Sanofi price target lowered to EUR 75 from EUR 800 at RBC Capital
The Fly22 · bearishanalyst
RXRX Stock Heads For Its Best Day In Over A Year – What’s Driving The Rally Today?
Stocktwits News67 · bullishproduct/pr
Recursion Pharmaceuticals Stock (RXRX) Soars 15% on a $10M Milestone Payment from Sanofi
TipRanks68 · bullishproduct/pr
Sanofi, pCPA sign letter of intent for Dupixent across four indications
The Fly63 · neutralproduct/pr
Recursion announces $200M equity offering, Sanofi milestone
Seeking Alpha38 · neutralgeneral
Recursion announces Sanofi option for development candidate
The Fly64 · neutralproduct/pr
Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their Collaboration
GlobeNewswire64 · neutralproduct/pr
Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their Collaboration
Business Insider64 · neutralproduct/pr
Sanofi evades EU fine for allegedly disparaging CSL’s flu vaccine
Seeking Alpha58 · neutralgeneral
EU accepts Sanofi’s concessions to end probe over vaccine marketing
The Fly62 · neutralgeneral